A personal breathing apparatus installed in an aircraft that is not fully pressurized, and configured to prevent or treat an adverse physiological event. The personal breathing system is configured so as to prevent, lessen or reverse hypercapnia by (i) facilitating removal of carbon dioxide generated the pilot by controlling pilot ventilation and/or (ii) limiting or decreasing the amount of carbon dioxide generated by the pilot by controlling the amount of oxygen breathed by the pilot.

An apparatus for treatment of a respiratory condition, the apparatus comprising: a pressure generator configured to generate a flow of breathable gas; an intermediate component pneumatically connected to an air delivery tube, the intermediate component comprising a port configured to facilitate propagation of sound outside of the intermediate component; a sensor attached externally to the intermediate component and located adjacent to the port of the intermediate component, the sensor configured to sense sound propagated through the air delivery tube; and a controller. The controller can be configured to: receive a sound signal generated by the sensor as a result of sensing sound during operation of the apparatus, analyse the received sound signal, and effect a response based at least in part on the analysing.

A medical gas delivery system and a ventilator system are provided. The medical gas delivery system includes an electrolytic gas generation device, a delivery device, and a control unit. The electrolytic gas generation device is used to generate a first gas and a second gas. The delivery device is in fluid communication with the electrolytic gas generation device, and is used to transport a medical gas. The medical gas includes at least one of the first gas and the second gas. The control unit is electrically connected with the electrolytic gas generation device and the delivery device, so as to control a component ratio of the medical gas.

A therapy of oxygen pulses delivered through the pulmonary system of human patient for treating neurodegenerative disorders such as Parkinson Disease (PD), Alzheimer's Disease (AD), Amiotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND) and other dementias, and Lymphedema, Arthritis and Depression is provided. Aspects of the methods including administering to the subjects an effective amount of oxygen as pulses through the respiratory tract are included. Also provided are methods of assessing severity of the disease, mild, moderate, severe, or critical, and oxygen doses and frequencies. The method can be applied to human patient for treating neurodegenerative disorders such as Parkinson Disease (PD), Alzheimer's Disease (AD) Amiotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND) and other dementias, and Lymphedema, arthritis and depression.

A method of estimating a parameter indicative of respiratory flow of a patient being administered flow therapy, comprising: optionally administering a gas at a flow rate to the patient using a flow therapy apparatus with a patient interface, determining a terminal pressure in, at or proximate the outlet of the patient interface or in, at or proximate the nares of the patient, determining nasal RTF, determining a nasal flow parameter being or indicative of nasal flow based on the pressure and a nasal RTF, and optionally outputting the nasal flow parameter or parameter derived therefrom.

A ventilation management system stores an initial configuration profile including a set of operating parameters for operating one or more respective ventilation devices. The system receives first ventilator data from a first ventilation device at a first location, and second ventilator data from a second ventilation device at a second location, the first and second ventilation devices being configured to operate based on the initial configuration profile, wherein the received first ventilator data comprises one or more current operating parameters of the first ventilation device, or physiological data obtained from a patient associated with the first ventilation device. The system modifies the initial configuration profile for use by the first ventilation device based on the received first ventilation data and provides the modified configuration profile to the first ventilation device. The modified configuration profile is implemented by the first ventilation device when approved by a clinician or the patient.

A humidification device that includes a case containing a humidification space in which water vapor is introduced to a feed gas to be fed to a user. heating unit configured to acquire electric energy using an electromagnetic induction phenomenon to generate heat is disposed in the humidification space. The humidification device further includes a coil configured to transfer energy to the heating unit by the electromagnetic induction phenomenon, an insulating unit configured to spatially separate the heating unit and the coil to prevent electrical contact therebetween and a liquid supply unit configured to supply, to the heating unit, a liquid to be vaporized into the water vapor. This provides a humidification device that can be made smaller in size and lighter in weight, and that can quickly and sufficiently humidify a gas without heating an entire body of water to be stored, as well as a respiratory assistance device.

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.

The Intelligent Automatic Oxygen Therapy System provides a device that allows the automatic and intelligent dosage of the percentage of an oxygen/air gas mixture and the flow delivered to each patient through non-invasive oxygen therapy procedures, based on the analysis of several measured variables that confirm the SpO2 value before taking any action. This device allows to measure biomedical signs with the main object of monitoring the oxygen saturation (SpO2), confirming its value with the analysis of the mentioned signs according to their concordance and interrelationship with each other. The equipment through artificial intelligence detects events that can occur due to the movement or for misplaced sensors. It also keeps and analyzes the records of the patient, evaluates the alarms in an intelligent way by correlating all acquired data; with this analysis the equipment can automatically and reliably provide the oxygen/air mixture adequate for each patient, with five operation modes. It activates the processed and valid alarms in an intelligent way and informs in a timely manner to the personal staff about possible found pathologies.

Embodiments provide an oxygen supply device having multiple operational states including a first state and a second state. In the first state, the oxygen supply device is controllable to a local control instruction such that the oxygen supply device can be operated by a user physically located within a proximity of the oxygen supply device. In the second state, the oxygen supply device is only controllable to a remote-control instruction such that the oxygen supply device can be operated by a user remote to the oxygen supply device. For example, the user can be located in an office remote to a location of the oxygen supply device, which, for example, may be placed at a patient's home. In the second state, the user is enabled to control the oxygen supply device from a device associated with the user in the remote location.